WeVote
Log In

Bill

Bill

SB 212

Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

2025-2026 Regular Session Introduced by Dinah Sykes

Kansas creates a prescription drug pricing board to review medication costs and set upper payment limits on select drugs to improve affordability.

Died in Committee
#insurance #namedacts #pharmacistsandpharmacy
0
WeVote Research Nonpartisan
Bill Summary · SB 212

Legislative bill overview

SB 212 creates a new state agency—the Prescription Drug Pricing Board—along with a stakeholder council to review prescription drug costs in Kansas and set upper payment limits (price caps) on certain medications. The bill establishes a regulatory framework for controlling what consumers and the state pay for drugs within Kansas.

Why is this important

Prescription drug costs are a major healthcare expense for individuals and state programs like Medicaid. This bill attempts to address affordability by giving the state direct authority to negotiate or cap drug prices, which could reduce out-of-pocket costs but may also affect drug availability, pharmaceutical company willingness to market drugs in Kansas, or speed of access to new medications.

Potential points of contention

  • Federal authority questions: Drug pricing is heavily regulated federally by the FDA and Medicare; states have limited authority, and this board's power versus federal law remains unclear
  • Market effects: Pharmaceutical companies may delay releasing new drugs in Kansas or reduce supply if price caps are too restrictive, potentially harming patient access
  • Implementation costs: Establishing and operating a pricing board requires funding and expertise; unclear whether Kansas has capacity for complex drug cost analysis and price-setting negotiations
  • Scope ambiguity: The bill's definition of "certain prescription drugs" is vague—which drugs qualify, and who decides?

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.